Kanabo Research
Kanabo focuses on vaporization for medical application developing targeted cannabis formulations designed to work in synergy with their medically certified delivery systems.
Kanabo research. Dec 2 reuters israel s kanabo research has agreed to be bought by cash shell spinnaker opportunities sop l in what could lead to the first listing of a cannabis company on london s main stock. Cannabis consumption now safer and. Kanabo research is an r d company based in israel that innovates cutting edge solutions for the medical cannabis industry. Kanabo research a tel aviv based medical cannabis company is aiming its vaporization formulations and devices at medical patients instead of the recreational users more commonly associated with.
It focuses on the distribution of cannabis derived products for medical patients and non thc products for cbd consumers. Kanabo is creating a new standard in the medical cannabis industry by building a holistic ecosystem that works together in synergy to improve the well being of millions around the world. Kanabo focuses on building medically validated ip that includes delivery. The formulations will begin undergoing clinical validation.
An outstanding product demands outstanding research. Kanabo research an r d company based in israel creates innovative solutions for the medical cannabis industry. Kanabo research is an r d company that innovates cutting edge solutions for the medical cannabis industry. Kanabo develops thc formulas for cns disorders and non thc.
Extracted cannabis formulas made to improve life quality. Kanabo focuses on building medically validated ip that includes delivery systems. Kanabo research is a biotech company that specializes in the medical cannabis industry. Tel aviv based kanabo research is a medical cannabis r d company.